56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer

ABSTRACT IMPACT: Identifying an important pathway in treatment resistant TNBC will allow for the future development of clinical therapeutics specific for this disease. OBJECTIVES/GOALS: Triple Negative Breast Cancer (TNBC) is a subtype of breast cancer characterized by negative expression of estroge...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Khoa, Alzoubi, Madlin, Hebert, Katherine, Cheng, Thomas, Elliott, Steven, Burow, Matthew, Collins-Burow, Bridgette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827792/
http://dx.doi.org/10.1017/cts.2021.442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827792/
http://dx.doi.org/10.1017/cts.2021.442

Ejemplares similares